CINECA IRIS Institutional Research Information System

CORCIONE, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.673
EU - Europa 4.320
AS - Asia 2.677
SA - Sud America 585
AF - Africa 158
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 28
Totale 14.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.509
IT - Italia 1.432
CN - Cina 993
IE - Irlanda 485
SG - Singapore 456
SE - Svezia 453
FR - Francia 287
DE - Germania 270
PE - Perù 206
VN - Vietnam 204
GB - Regno Unito 188
ES - Italia 182
DK - Danimarca 177
IN - India 164
FI - Finlandia 163
UA - Ucraina 149
TR - Turchia 134
ID - Indonesia 126
AR - Argentina 111
CL - Cile 107
HK - Hong Kong 91
AU - Australia 90
PL - Polonia 88
JP - Giappone 86
AT - Austria 81
KR - Corea 80
BR - Brasile 77
MX - Messico 77
BE - Belgio 74
CA - Canada 72
NL - Olanda 51
IR - Iran 49
TH - Thailandia 47
CO - Colombia 44
SA - Arabia Saudita 42
RU - Federazione Russa 41
GR - Grecia 40
ZA - Sudafrica 36
RO - Romania 31
EG - Egitto 27
MY - Malesia 25
TW - Taiwan 25
PK - Pakistan 24
CZ - Repubblica Ceca 23
PT - Portogallo 21
EU - Europa 20
MA - Marocco 19
PH - Filippine 18
TN - Tunisia 18
CH - Svizzera 17
BO - Bolivia 16
EC - Ecuador 16
UZ - Uzbekistan 14
JO - Giordania 13
LB - Libano 12
SI - Slovenia 12
AE - Emirati Arabi Uniti 11
NG - Nigeria 11
ET - Etiopia 10
IL - Israele 10
KZ - Kazakistan 10
LV - Lettonia 10
CR - Costa Rica 8
QA - Qatar 8
UG - Uganda 8
AP - ???statistics.table.value.countryCode.AP??? 7
BA - Bosnia-Erzegovina 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
BD - Bangladesh 6
BG - Bulgaria 6
MU - Mauritius 6
HU - Ungheria 5
NP - Nepal 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
DZ - Algeria 4
GT - Guatemala 4
HR - Croazia 4
IQ - Iraq 4
LY - Libia 4
BY - Bielorussia 3
KE - Kenya 3
MD - Moldavia 3
PY - Paraguay 3
RS - Serbia 3
AO - Angola 2
BH - Bahrain 2
GH - Ghana 2
KW - Kuwait 2
LT - Lituania 2
LU - Lussemburgo 2
MN - Mongolia 2
PA - Panama 2
RE - Reunion 2
RW - Ruanda 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
Totale 14.529
Salva come PNG Salva come JPEG
Città #
Chandler 972
Houston 482
Ann Arbor 478
Dublin 477
Fairfield 421
Singapore 355
Beijing 308
Torino 297
Ashburn 224
Nyköping 193
Wilmington 178
Woodbridge 171
Lima 149
Cambridge 138
Turin 137
Medford 136
Seattle 127
Villeurbanne 126
Princeton 125
Jakarta 114
Redwood City 113
Pisa 99
Milan 94
Dearborn 86
Guangzhou 80
Dong Ket 79
Fremont 79
Jacksonville 75
Hangzhou 74
Warsaw 69
Vienna 64
Shanghai 58
Santa Clara 56
Brussels 53
Santiago 53
New York 52
Rome 51
Hebei 46
San Diego 46
Madrid 41
Boardman 40
Boston 38
Lappeenranta 38
Paris 36
Chengdu 34
Helsinki 34
Nanjing 33
Seoul 33
Ankara 30
Istanbul 30
Barcelona 29
Central 28
Hong Kong 27
Washington 25
Los Angeles 23
Norwalk 23
Philadelphia 23
London 22
Buenos Aires 20
Padova 20
Riyadh 20
Upper Marlboro 20
Bogotá 19
Guiyang 19
Munich 19
Toronto 19
Palermo 18
Sydney 18
Tokyo 18
Fuzhou 17
San Miguel de Tucumán 17
Verona 17
Columbus 16
Federal 16
Hefei 16
Mexico City 16
Huancayo 15
Jinan 15
Phoenix 15
Silver Spring 15
Athens 14
Bangkok 14
Berlin 14
Naples 14
Bucharest 13
Chennai 13
Chicago 13
Denver 13
Falls Church 13
Genoa 13
Nanchang 13
Portland 13
Johannesburg 12
Melbourne 12
Pittsburgh 12
Taipei 12
Arequipa 11
Hamburg 11
Jeddah 11
La Paz 11
Totale 8.159
Salva come PNG Salva come JPEG
Nome #
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review 1.284
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation 878
Antimicrobial prophylaxis in minor and major surgery. 445
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. 332
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 329
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study 298
Re-defining tigecycline therapy 288
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? 282
Antimicrobial stewardship in a long-term acute care hospital using offsite electronic medical record audit 264
Anidulafungin for Candida glabrata Infective Endocarditis 243
High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. 234
Health-care Associated KPC-BSI: The Time Has Come. 232
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH 212
Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results 209
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome 203
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation? 179
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis 173
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. 171
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 170
Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection 166
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. 166
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 157
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE 156
Clinical pharmacology of complex regiment of antiretroviral therapy including Etravirine, Maraviroc and Raltégravir. 149
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. 141
Start Smart with Antimicrobial Stewardship 137
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis 134
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project 130
Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study 125
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study 118
A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: Beyond the ICU 117
The effect on mortality of fluconazole or echinocandins treatment in internal medicine wards 115
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 114
Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital. 113
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients 112
Surgical antimicrobial prophylaxis prescribing practices and impact on infection risk: Results from a multicenter surveillance study in Italy (2012-2017) 111
From ESKAPE to ESCAPE, From KPC to CCC. 110
Management of carbapenem-resistant K. pneumoniae in allogenic stem cell transplant recipients: the Turin bundle 109
Pharmacokinetics of Meropenem in Burn Patients with Infections Caused by Gram Negative Bacteria: Are We Getting Close to the Right Treatment? 107
Wound botulism after traumatic open fracture in Italy 104
Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci 102
Mortality in early- and late-onset candidemia 100
First case of E. meningoseptica in Italy in a patient with necrotic hemorrhagic pancreatitis 99
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 96
Neurological disease may precede lymphadenopathies in Actinomyces europaeus infection 95
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge 94
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 93
The "scar" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy 87
Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study 87
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball 85
Staphylococcus aureus producing Panton-Valentine Leukocidin: An emerging problem in Italian ICUs 84
A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome 82
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 81
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots 81
Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections 80
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 76
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 76
Choosing wisely: what's the actual role of antimicrobial stewardship in intensive care units? 75
Pharmacogenomic influence on sepsis outcome in critically ill patients 75
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy 74
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients-authors' response 73
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage 73
Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry 73
Real-life use of isavuconazole outside the hematological wards. 70
Ceftazidime-avibactam susceptible to resistant KPC-producing Enterobacterales bloodstream infections: an observational study 69
Current and future therapies for invasive aspergillosis. 68
Cost‐effectiveness analysis of the prophylactic use of ertapenem for the prevention of surgical site infections after elective colorectal surgery 68
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 67
Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata 66
Antibiotic de-escalation experience in the setting of emergency department: A retrospective, observational study 66
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 65
A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance 65
Erratum to Pharmacokinetics of high dosage of linezolid in two morbidly obese patients [J Antimicrob Chemother, (2015), 70, 2417-2418] 65
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients 64
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 64
Pharmacokinetic of caspofungin in patients with invasive candidiasis 63
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 63
Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes? 62
New cephalosporins for the treatment of pneumonia in internal medicine wards 60
Giardiasis reactivation during severe SARS-CoV-2 infection 59
Guida Lippincott alle Malattie Infettive 58
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 57
Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection 57
Skin and soft tissue infections after breast surgery 57
Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach 57
Clinical experience with ceftazidime-avibactam for the treatment of infections due to multidrug-resistant gram-negative bacteria other than carbapenem-resistant Enterobacterales 56
Liver transplantation with an uncommon full right hemiliver graft after hydatid cysts resection: Case report and review of the literature 56
Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study 56
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 55
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration 54
COVID-19 pneumonia: Do not leave the corticosteroids behind! 54
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements 54
Visceral leishmaniasis in a patient with active HBV/HDV co-infection 53
Ozone therapy in COVID-19: A narrative review 53
Use of colistin in adult patients: A cross-sectional study 53
Carbapenemase-producing klebsiella pneumoniae colonization and infection in solid organ transplant recipients: A single-center, retrospective study 53
Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient Context 52
Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital 51
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 50
Point prevalence data on antimicrobial usage in Italian acute-care hospitals: Evaluation and comparison of results from two national surveys (2011-2016) 49
Totale 13.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.192
article - articoli 0
book - libri 0
conference - conferenze 1.003
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.504 0 0 59 166 149 411 133 125 129 132 94 106
2020/20211.606 81 83 73 91 114 78 87 77 123 240 181 378
2021/20222.451 183 145 174 189 171 211 150 137 129 164 434 364
2022/20233.635 312 294 211 324 314 715 220 277 387 145 250 186
2023/20242.368 239 353 128 148 187 218 153 163 76 215 213 275
2024/2025913 233 375 305 0 0 0 0 0 0 0 0 0
Totale 15.118